Background-Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue. Objective-To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. Methods and Results-Male ␤ 2 -microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, ␣-galactosylceramide, 0.1 g/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. ␣-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue.
O besity, specifically visceral obesity, increases the risk for metabolic disorders, such as type 2 diabetes mellitus, dyslipidemia, and hypertension as well as atherosclerotic cardiovascular diseases. Previous studies have demonstrated that the accumulation of macrophages within adipose tissue is well documented in obese individuals and that adipose tissue inflammation plays an important role in the pathogenesis of these metabolic disorders. 1, 2 Macrophages are attracted by chemokines, such as monocyte chemoattractant protein 1 (MCP-1), and contribute to local inflammation through the release of other inflammatory cytokines, such as tumor necrosis factor (TNF) ␣. In high-fat diet (HFD)-fed obese mice, it has been shown that infiltration of macrophages into adipose tissue coincides with the occurrence of obesitymediated metabolic disorders. 2 The important role of adipose tissue macrophages in the pathogenesis of metabolic disorders has further been supported by recent data in C-C motif chemokine receptor 2 (CCR2)-deficient mice. 3 The CCR2 Ϫ/Ϫ mice exhibited a reduction in adipose tissue macrophages in association with an improvement of glucose homeostasis and insulin sensitivity. However, the abolished monocyte and macrophage recruitment into peripheral tissue via interaction with MCP-1 could not completely inhibit HFD-mediated metabolic disorders, suggesting that other inflammatory cells may play a role in this context. Wu et al 4 and Rocha et al 5 demonstrated that CD3-positive T lymphocytes are present in human adipose tissue; and regulated upon activation, normal T cell expressed secreted (RANTES), a T-cell-specific chemokine, and its respective receptor CCR5 are expressed in adipose tissue from obese patients. However, the role of other types of lymphocytes in adipose tissue inflammation is largely unexplored.
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Natural killer T (NKT) cells are innatelike T lymphocytes that recognize glycolipid antigens and are capable of rapidly producing a mixture of T-helper type 1 (T H 1) and T H 2 cytokines, such as interferon (IFN) ␥ and interleukin (IL) 4 in shaping subsequent adaptive immune responses. 6 Thus, NKT cells can function as a bridge between the innate and adaptive immune systems. Caspar-Bauguil et al 7 have reported the presence of significant levels of NKT cells in the stromavascular fraction of white adipose tissue by cytofluorometric analysis. However, they have not determined whether NKT cells are involved in adipose tissue inflammation and the development of metabolic disorders, including glucose intolerance in HFD-induced obesity.
Some of the processes involved in adipose tissue inflammation resemble inflammatory processes in atherogenesis. 8 Inflammation during the development of an atherosclerotic lesion is also characterized by monocyte/macrophage and lymphocyte infiltration. 8 These lymphocytes are mainly CD4positive lymphocytes that express proinflammatory T H 1 cytokines, such as IFN-␥, and orchestrate the inflammatory response in the vascular wall by activating other cells. Previous studies, 9, 10 including our own studies, demonstrated that NKT cells were present in atherosclerotic lesions and are critically important in atherogenesis. These findings suggest that NKT cells can also be involved in inflammation within adipose tissue. However, to date, it remains unclear whether NKT cells play a similar role in adipose tissue inflammation.
In the present study, we determined whether NKT cells are involved in HFD-induced glucose intolerance and adipose tissue inflammation by using ␤ 2 microglobulin knockout (KO) mice lacking NKT cells. Moreover, we further examined the effects of NKT cell activation by ␣-galactosylceramide (␣GC), a specific activator for NKT cells, 11 on glucose intolerance and adipose tissue inflammation in HFD-induced obese mice.
Methods
Expanded materials and methods are available in the supplemental files (available online at http://atvb.ahajournals.org).
Experiment 1: The Effects of NKT Cell Depletion on Metabolic Disorders
Male wild-type (WT) (Charles River Japan, Inc, Yokohama, Japan) and KO mice, which lack NKT and T cells on the C57BL/6 background (The Jackson Laboratory, Bar Harbor, Maine), aged 8 weeks, were fed with a standard diet (SD) (WT-SD, nϭ10; and KO-SD, nϭ5) or an HFD containing 21% fat and 0.15% cholesterol (WT-HFD, nϭ10; and KO-HFD, nϭ14) for 13 weeks. Animals were metabolically phenotyped, including an intraperitoneal glucose tolerance test (ipGTT). Other WT mice, aged 8 weeks, were fed with an SD (nϭ15) or an HFD (nϭ15) for 2, 4, or 6 weeks. Afterward, animals underwent euthanasia and organs, including visceral adipose tissue, were dissected.
Experiment 2: The Effects of NKT Cell Activation on Metabolic Disorders
After feeding male WT and KO mice, aged 8 weeks, with an HFD for 13 weeks, phosphate-buffered saline (PBS) (WT-PBS, nϭ5; and KO-PBS, nϭ5) or ␣GC, 0.1 g/g body weight (Kirin Brewery Company, Ltd, Tokyo, Japan) (WT-␣GC, nϭ5; and KO-␣GC, nϭ5), was injected intraperitoneally. After 8 to 9 days, ipGTT was performed and visceral adipose tissues were dissected. Other WT mice, aged 8 weeks, were injected using PBS (nϭ9) or ␣GC, 0.1 g/g body weight (nϭ11) intraperitoneally and organs, including visceral adipose tissues, were dissected 1, 4, and 7 days after the injection.
The animal care and procedures for the experiments were approved by the Committee of Hokkaido University Graduate School of Medicine on Animal Experimentation.
Results

NKT Cell Depletion Ameliorates Metabolic Disorders in HFD-Fed Mice
To characterize the role of NKT cells in the pathogenesis of HFD-induced glucose intolerance and visceral adipose tissue inflammation, WT and KO mice were fed with either SD or HFD for 13 weeks.
The quantification of NKT cells by V␣14/J␣18 gene expression confirmed that NKT cell infiltration was significantly enhanced in adipose tissue from HFD mice and, more important, was completely abolished in KO groups ( Figure 1A ).
An HFD did not affect fasting plasma levels of glucose, insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) in WT-HFD and KO-HFD compared with WT-SD (Table 1 ). However, plasma glucose levels during ipGTT were significantly increased in WT-HFD than in WT-SD, and these values were significantly lower in KO-HFD ( Figure 1B) . The area under the curve values of plasma glucose levels during the ipGTT were significantly increased in WT-HFD, and this increase was attenuated in KO-HFD to the WT-SD levels ( Figure 1C ). These results demonstrated that glucose intolerance seen in HFD-fed mice was significantly ameliorated by the depletion of NKT cells. Plasma total cholesterol and leptin levels were also significantly increased by HFD but were not altered in KO-HFD. The plasma adiponectin level did not change in WT-HFD compared with WT-SD, but significantly increased in KO-HFD. The plasma glucagon level tended to be lower in KO-SD compared with WT-SD, which did not reach statistical significance (Table) . An HFD significantly increased the weight of visceral adipose tissue compared with groups fed with SD. An HFD significantly increased the weight of visceral adipose tissue compared with the weight of groups fed with SD. In parallel to visceral adipose tissue weight, adipocyte size measured by morphometric analysis was significantly increased in WT-HFD than in WT-SD. However, these increases were not altered in KO-HFD.
In parallel to the glucose intolerance, the infiltration of F4/80-positive macrophages by immunohistochemical staining was significantly increased in visceral adipose tissues from WT-HFD than WT-SD, and this increase was significantly ameliorated in KO-HFD (Figure 2A and B). Major histocompatibility complex (MHC) class II, CD11c, and arginase gene expression, measured by using real-time reverse transcriptase-polymerase chain reaction (a quantitative index of macrophage activation, M1 macrophage, and M2 macrophage, respectively), demonstrated that infiltrating macrophages possess a predominantly M1 phenotype in WT-HFD mice and an M2 phenotype in KO-HFD mice ( Figure 2C -E). Taken together, these data indicated that M1 macrophage infiltration was enhanced in adipose tissue from WT-HFD and that this increase was significantly ameliorated in KO-HFD accompanied by a phenotypic change into M2 macrophage.
To examine the temporal relationship between infiltrating NKT cells and macrophages within obese adipose tissues, WT mice were fed with SD or HFD for 2, 4, or 6 weeks. Quantification of NKT cells by V␣14/J␣18 gene expression demonstrated that NKT cell infiltration was significantly increased after 6 weeks of HFD feeding, whereas macrophages quantified by F4/80 gene expression were not increased during the same period in visceral adipose tissues (supplemental Figure 1A and B). Similarly, in subcutaneous fat tissues, NKT cell infiltration was significantly increased after 4 weeks of HFD feeding, whereas macrophages were not increased during the same period (supplemental Figure  1C and D). More important, macrophages were significantly increased at 13 weeks of HFD feeding. Combining the data from weeks 2 to 6 (supplemental Figure 1 ) with those from week 13 ( Figure 2B ), the infiltration of NKT cells preceded that of macrophages in obese adipose tissues. Therefore, the occurrence of glucose intolerance and macrophage infiltration into adipose tissue from HFD-induced obese mice is mediated by NKT cells.
To examine the role of NKT cells in gluconeogenesis, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene expression were measured in the hepatic tissues. Hepatic gluconeogenesis tended to be suppressed in KO-SD compared with WT-SD, which did not reach statistical significance (supplemental Figure 2 ).
NKT Cell Activation Exacerbated Metabolic Disorders in HFD-Fed Mice
To further characterize the role of NKT cells in the pathogenesis of HFD-induced glucose intolerance and visceral adipose tissue inflammation, ␣GC was injected intraperitoneally in WT mice fed HFD for 13 weeks.
␣GC did not affect body weight, visceral adipose tissue weight, and adipocyte size in HFD mice 9 days after injection (supplemental Table) .
The quantification of NKT cells by V␣14/J␣18 gene expression confirmed ␣GC significantly enhanced NKT cell infiltration into adipose tissue ( Figure 3A ). Plasma glucose levels during ipGTT were significantly increased by ␣GC (15 minutes: 330 [11] Figure 3B ). F4/80-positive macrophage infiltration was significantly increased in the adipose tissues for WT mice by ␣GC ( Figure  4A and B) . These changes of adipose tissue macrophages by the immunohistochemical analysis were also confirmed by MHC class II and CD11c gene expression ( Figure 4C and D) . In parallel to macrophage infiltration into the visceral adipose tissue, the injection of ␣GC significantly increased the expression of MCP-1, TNF-␣, IFN-␥, and RANTES genes in HFD mice ( Figure 5A-D) .
To examine the temporal relationship between infiltrating NKT cells and macrophages, WT mice, aged 8 weeks, were injected using PBS or ␣GC intraperitoneally and adipose tissues were dissected 1, 4, and 7 days after the injection. The NKT cells and macrophages tended to increase at 4 and 7 days after ␣GC administration in WT mice (supplemental Figure 3) .
To examine the effects of ␣GC treatment on the metabolic phenotypes of genetically induced obese mice, ␣GC was injected intraperitoneally in ob/ob mice. Natural killer T cell and macrophage infiltration were significantly increased in ␣GC-treated ob/ob mice compared with PBS-treated ob/ob mice (supplemental Figure 4A and B) . Major histocompatibility complex class II, CD11c, and arginase gene expression were also significantly increased in ␣GC-treated ob/ob mice (supplemental Figure 4C -E). Similar to diet-induced obese mice, the injection of ␣GC significantly enhanced the expression of TNF-␣, IFN-␥, and RANTES genes, also in ob/ob mice (supplemental Figure 4G -I). Plasma glucose levels during ipGTT in ␣GC-treated ob/ob mice were comparable to those in PBS-treated ob/ob mice (supplemental Figure 5) .
To confirm the specificity of ␣GC treatment for activating NKT cells, ␣GC was injected in KO mice fed HFD for 13 weeks. It did not affect NKT cell and macrophage infiltration in the adipose tissues and plasma glucose levels during ipGTT in KO mice (supplemental Figure 6) .
To assess the direct relationship between NKT cell activation and adipose tissue inflammation, splenic CD11b ϩ Gr1 Ϫ CD4 Ϫ CD8 Ϫ B220 Ϫ cells (macrophage-enriched cells) and liver MHC-classII Ϫ CD8 Ϫ B220 Ϫ lymphocytes (NKT-enriched cells) were cocultured with or without ␣GC for 48 hours. Macrophages conditioned with activated NKT cells by ␣GC secreted a significantly larger amount of MCP-1 into the coculture media compared with unconditioned macrophages (supplemental Figure 7 ).
Discussion
The present study demonstrated that NKT cells were infiltrated into the visceral adipose tissue in association with macrophages during the development of glucose intolerance in a mouse model of HFD-induced obesity. The depletion of NKT cells in ␤ 2 microglobulin KO mice ameliorated glucose intolerance and visceral adipose tissue inflammation induced by HFD feeding without affecting obesity itself. On the contrary, the activation of NKT cells by ␣GC exacerbated glucose intolerance and adipose tissue inflammation, including macrophage infiltration and inflammatory cytokine/chemokine gene expression. Therefore, NKT cells may play a pivotal role in the development of glucose intolerance and adipose tissue inflammation associated with HFD-induced obesity.
Visceral obesity has been demonstrated to be associated with macrophage infiltration and inflammation in adipose tissue. 1, 2, 12 As such, MCP-1 is produced by adipocytes in parallel with increasing adiposity, and mice lacking CCR2, a receptor for MCP-1, exhibit less macrophage infiltration in adipose tissues and a reduction in inflammatory gene expression. 2 However, the development of HFD-induced glucose intolerance was not completely abolished in these mice, suggesting that the other chemokine systems might also contribute to obesity-related adipose tissue inflammation and glucose intolerance.
Early work by cytofluorometric analysis revealed the presence of significant levels of NKT cells in the stromavascular fraction of white adipose tissues. 7 However, the changes of these cells by HFD feeding and even their roles in HFD-induced metabolic disorders have not been examined. In the present study, depleting NKT cells significantly ameliorated glucose intolerance after HFD feeding (Figure 1 ). Therefore, our study has extended the previous information on the significance of NKT cells by demonstrating that the cell infiltration of these cells into the adipose tissue is involved in the recruitment of macrophages and inflammatory cytokine gene expression during the development of HFD-induced glucose intolerance. However, the present results were not consistent with those of the previous study by Elinav et al, 13 which noted that NKT cells ameliorated glucose intolerance in leptin-deficient ob/ob mice. In their study, the oral administration of liver extracts in ob/ob mice increased hepatic NKT cells and serum levels of IL-10, indicating that the extracts activated NKT cells toward the T H 2 bias, whereas ␣GC injection stimulated NKT cells toward the T H 1 slant in the present study. Therefore, the discrepancy between these studies might be the result of the differences in the methods of modulating NKT cells and the resultant changes of cytokines subsequent to NKT cell activation. The differences in the animal models (HFD-induced obese mice vs leptin-deficient ob/ob mice) might also be involved in this discrepancy because the injection of ␣GC significantly enhanced the expression of arginase in ob/ob mice but not in HFD-induced obese mice. Previous studies demonstrated that proinflammatory T lymphocytes are also present in visceral adipose tissue and contribute to adipose tissue inflammation and the development of glucose intolerance before the recruitment of macrophages. 4 A recent elegant study by Nishimura et al 14 elucidated the role of T lymphocytes in adipose tissue inflammation in obesity. In their study, many CD8 ϩ effector T cells infiltrated into obese epididymal adipose tissue, preceding macrophage infiltration, in HFD-induced obese mice and initiated the inflammatory cascade that leads to insulin resistance in adipocytes. We could not completely exclude the possibility that T lymphocytes are involved in our model because ␤ 2 microglobulin KO mice used in the present study lack not only NKT cells but also CD8 ϩ T lymphocytes. 15 However, the development of both glucose intolerance and adipose tissue inflammation induced by HFD was significantly exacerbated by the specific activation of NKT cells by using ␣GC, an activator of NKT cells but not T cells (Figures 3-5 ). Based on these results, we consider that NKT cells are critically involved in glucose intolerance and adipose tissue inflammation in obese mice.
The NKT cells are a specialized lineage of T cells that recognize glycolipid antigens presented by the MHC class I-like molecule CD1d. 16 The NKT cells mediate various functions rapidly by producing a mixture of T H 1 and T H 2 cytokines, such as IFN-␥ and IL-4, in shaping subsequent adaptive immune responses. 6 The present study demonstrated that accumulated macrophages in adipose tissues in ␣GCtreated mice were classically activated (M1) macrophages, one of the distinct subsets of macrophages categorized as M1 by CD11c (Figure 4 ). 17, 18 In agreement with these findings, the activation of NKT cells was associated with increased gene expression of T H 1-cytokine IFN-␥ and MCP-1 in HFD-fed mice ( Figure 5 ). Interferon-␥ can also promote the recruitment of monocytes by inducing MCP-1 secretion from periadipocytes, and it could activate other cells, such as macrophages. Therefore, cytokines and chemokines, including IFN-␥ and MCP-1, were mechanistically involved in the infiltration of macrophages as a result of NKT cell activation. The NKT cells may orchestrate the inflammatory process in adipose tissue in association with the development of glucose intolerance. The beneficial effects of depleting NKT cells are mostly mediated by the reduction of macrophages. It may be informative to examine whether immunosuppressive agents, such as cyclosporine and tacrolimus, which have been shown to suppress ␣GC-induced cytokine production in murine NKT cells, 19, 20 can ameliorate adipose tissue inflammation and glucose intolerance in our model. However, they also induce glucose intolerance via its toxic effects on the pancreatic islet cells. 21, 22 Therefore, these reagents may not be suitable for investigating the role of NKT cells in glucose intolerance in HFD-induced obesity in vivo.
The underlying mechanisms responsible for the activation of NKT cells by the HFD feeding remain established. Based on our results using ␣GC, a glycosphingolipid derived from marine sponges, sphingolipid ceramide may be a crucial intermediate linking between excess nutrients by HFD and inflammatory cytokines to induce glucose intolerance. In fact, ceramide has been shown to be synthesized by long-chain fatty acids and to induce both inflammation and insulin resis-tance. 23 In agreement with our results, Rocha et al 5 reported that the HFD feeding increases a number of T cells and IFN-␥ gene expression in adipose tissue, suggesting T-cell priming toward the T H 1 slant. However, the HFD feeding has been shown to suppress T H 1 responses in B6 mice by inhibiting toll-like receptor-mediated maturation and proinflammatory cytokine production in dendritic cells. 24 The discrepancy between these studies might be the result of the differences in the tissues studied (visceral adipose tissue lymphocytes vs splenic lymphocytes). More important, the contribution of NKT cells is not mediated by the modulation of adipose tissue weight or adipocyte size because these variables did not differ between HFD-fed groups ( Table 1 and Supplemental Table) ; however, adipocyte cell size has been shown to be an independent predictor of glucose intolerance. 25 Activated macrophages secrete TNF-␣, which can inhibit insulin signal transduction. 26 Obesity itself can trigger adipose tissue inflammation, which leads to the desensitization of insulin action. 27 We have demonstrated that NKT cells may be important in the evolution of atherosclerotic lesions by communicating macrophages through cell-cell interactions and/or secreting inflammatory cytokines. 10 Some of the inflammatory processes involved in atherogenesis (as shown in our previous study) resemble adipose tissue inflammation in the present study. Therefore, NKT cells are considered to mediate chronic inflammation in vascular and adipose tissues and can represent a direct and common soil for the development of atherosclerotic cardiovascular disease and diabetes. An in vivo transfer experiment with isolated NKT cells may provide more direct evidence of the cause-and-effect relationship between NKT cells and glucose intolerance associated with HFD-induced obesity. Nevertheless, ␣GC has been established to be a specific activator for NKT cells and, in fact, it has been used in a variety of disease models to elucidate the pathogenetic role of NKT cells. 28 Therefore, we used ␣GC administration to activate NKT cells in the present study. There are several limitations to be acknowledged in the present study. First, we only examined the adipose tissue in the present study and did not assess the contribution of liver or skeletal muscle, which can also determine insulin sensitivity. 1 Fasting plasma glucose level and HOMA-IR were significantly lower in KO-SD than in WT-SD (Table) . Knockout-SD mice tended to have lower plasma glucose levels and area under the curve values during ipGTT compared with WT-SD ( Figure 1B and C); this finding did not reach statistical significance. These data suggested that the absence of NKT cells could improve glucose metabolism in healthy mice, independently of adipose tissue inflammation. It may be possible that NKT cells affect glucose metabolism via the alterations of gluconeogenesis in the liver and skeletal muscle. However, based on the results that the improvement of glucose metabolism is relatively small in KO-SD mice (Figure 1 ), we consider that NKT cells may impair glucose tolerance predominately via promoting adipose tissue inflammation exclusively in HFD-fed mice. Second, there was massive macrophage infiltration in the adipose tissue in our HFD-fed mice even though the weight gain was relatively small. The NKT cell infiltration preceded macrophage infiltration in obese visceral adipose tissues and may play an important role in the early phase of adipose tissue inflammation. Therefore, even though we have not examined how much NKT cells and macrophages infiltrate within adipose tissues during the development of more severe obesity, we consider that the deletion of NKT cells can effectively attenuate the infiltration of macrophages in this setting. In contrast, the activation of NKT cells has been reported to be protective against type 1 diabetes, systemic lupus erythematosus, and infections. 29 Therefore, the inhibition of NKT cells as a therapeutic strategy to prevent and treat metabolic syndrome and cardiovascular disease for obese individuals needs to be used cautiously in the setting of these disease conditions.
In conclusion, the depletion of NKT cells ameliorated chronic inflammation in visceral adipose tissues and suppressed the development of glucose intolerance in HFDinduced obese mice. On the other hand, the activation of NKT cells exacerbated macrophage infiltration in adipose tissue and glucose intolerance with obesity. Therefore, NKT cells enhance chronic inflammation in visceral adipose tissue and contribute to the development of metabolic disorders in obesity. The NKT cells may be the novel therapeutic targets in atherosclerosis, metabolic syndrome, and type 2 diabetes.
